How does donanemab compare to lecanemab for alzheimers

Donanemab and lecanemab are the two most significant anti-amyloid antibody treatments to emerge from Alzheimer's research in recent years, and while they...

Donanemab and lecanemab are the two most significant anti-amyloid antibody treatments to emerge from Alzheimer's research in recent years, and while they...

Cholinesterase inhibitors are the primary pharmacological treatment for Alzheimer's disease and several other forms of dementia.

CBD oil may offer some relief from certain dementia symptoms — particularly agitation and anxiety — but it cannot stop, reverse, or prevent dementia...

Benzodiazepines pose serious, well-documented dangers for elderly patients with dementia — and the risks go well beyond simple drowsiness.

Melatonin is generally considered low-risk for short-term use in people with dementia, but the picture is more complicated than a simple yes or no.

Galantamine is a moderately effective treatment for mild Alzheimer's disease, with clinical trials consistently showing improvements in cognitive...

Aricept and Namenda are both FDA-approved medications for Alzheimer's disease, but they work through entirely different mechanisms and are approved for...

Antipsychotic medications can be used in dementia patients, but they cannot be considered "safe" in any straightforward sense of the word.

The newest FDA-approved treatments for Alzheimer's disease represent a genuine turning point in how medicine approaches the condition.

Memantine is effective for moderate to severe dementia, and the evidence supporting that conclusion is both substantial and consistent.